Suppression of p53-dependent senescence by the JNK signal transduction pathway

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 40, 2007, Pages 15759-15764

  Das, Madhumita ^a   Jiang, Feng ^a   Sluss, Hayla K ^a   Zhang, Chao ^b   Shokat, Kevan M ^b   Flavell, Richard A ^c   Davis, Roger J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AP1; Cell cycle; cJun

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; PROTEIN C JUN; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR JUND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME DEFICIENCY; ENZYME REPRESSION; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE; SIGNAL TRANSDUCTION;

ANIMALS; CELL AGING; CELL DIVISION; FIBROBLASTS; GENES, P53; KINETICS; MAP KINASE KINASE 4; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 8; POLYMERASE CHAIN REACTION; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-JUN; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

MURINAE;

EID: 35648935982     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0707782104     Document Type: Article

References (25)

1. Davis RJ (2000) Cell 103:239-252.
2. Jochum W, Passegue E, Wagner EF (2001) Oncogene 20:2401-2412.
3. Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, Davis RJ (2000) Science 288:870-874.
4. Manning AM, Davis RJ (2003) Nat Rev Drug Discov 2:554-565.
5. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Derijard B, Davis RJ (1996) EMBO J 15:2760-2770.
6. Lamb JA, Ventura JJ, Hess P, Flavell RA, Davis RJ (2003) Mol Cell 11:1479-1489.
7. Musti AM, Treier M, Bohmann D (1997) Science 275:400-402.
8. Fuchs SY, Dolan L, Davis RJ, Ronai Z (1996) Oncogene 13:1531-1535.
9. Weitzman JB, Fiette L, Matsuo K, Yaniv M (2000) Mol Cell 6:1109-1119.
10. Johnson RS, van Lingen B, Papaioannou VE, Spiegelman BM (1993) Genes Dev 7:1309-1317.
11. Dimri GP, Campisi J (1994) Cold Spring Harb Symp Quant Biol 59:67-73.
12. Fuchs SY, Fried VA, Ronai Z (1998) Oncogene 17:1483-1490.
13. Jaeschke A, Karasarides M, Ventura J-J, Ehrhardt A, Zhang C, Flavell RA, Shokat KM, Davis RJ (2006) Mol Cell 23:899-911.
14. Ventura JJ, Hubner A, Zhang C, Flavell RA, Shokat KM, Davis RJ (2006) Mol Cell 21:701-710.
15. Sherr CJ (2001) Nat Rev Mol Cell Biol 2:731-737.
16. Schreiber M, Kolbus A, Piu F, Szabowski A, Mohle-Steinlein U, Tian J, Karin M, Angel P, Wagner EF (1999) Genes Dev 13:607-619.
17. Weston CR, Davis RJ (2007) Curr Opin Cell Biol 19:142-149.
18. Dong C, Yang DD, Tournier C, Whitmarsh AJ, Xu J, Davis RJ, Flavell RA (2000) Nature 405:91-94.
19. Yang DD, Conze D, Whitmarsh AJ, Barrett T, Davis RJ, Rincon M, Flavell RA (1998) Immunity 9:575-585.
20. Badea TC, Wang Y, Nathans J (2003) J Neurosci 23:2314-2322.
21. Silver DP, Livingston DM (2001) Mol Cell 8:233-243.
22. Halbert CL, Demers GW, Galloway DA (1992) J Virol 66:2125-2134.
23. Todaro GJ, Green H (1963) J Cell Biol 17:299-313.
24. Hess P, Pihan G, Sawyers CL, Flavell RA, Davis RJ (2002) Nat Genet 32:201-205.
25. Ventura JJ, Cogswell P, Flavell RA, Baldwin AS, Jr, Davis RJ (2004) Genes Dev 18:2905-2915.